Explore relationships

Reolysin

Pelareorep (previously known under the trademark Reolysin) is a proprietary isolate of the unmodified human reovirus being developed as a systemically administered immuno-oncological viral agent for the treatment of solid tumors and hematological malignancies.

Use + to expand a branch. Click a topic name to open its summary.